BNP Paribas Asset Management
BLFS icon

BNP Paribas Asset Management’s BioLife Solutions BLFS Stock Holding History

BNP Paribas Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Sell
609
-398
-40% -$9.3K ﹤0.01% 2090
2026
Q1 		$19.2K Buy
1,007
+307
+44% +$6.79K ﹤0.01% 2044
2025
Q4 		$17K Buy
700
+209
+43% +$5.47K ﹤0.01% 1998
2025
Q3 		$13K Buy
491
+151
+44% +$3.58K ﹤0.01% 1544
2025
Q2 		$7K Buy
+340
New +$7.66K ﹤0.01% 1874

Other funds holding BLFS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

BNP Paribas Asset Management's BLFS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its BioLife Solutions (BLFS) stake by 40% in Q2 2026, selling an estimated $9.3K and leaving 609 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

BNP Paribas Asset Management first reported a position in BLFS in Q2 2025 and has held it in 5 quarters since. The position peaked at $19.2K in Q1 2026. 159 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • BNP Paribas Asset Management held 609 shares of BioLife Solutions worth $17.2K as of Q2 2026.
  • BNP Paribas Asset Management sold 398 BioLife Solutions shares in Q2 2026, an estimated $9.3K.
  • BioLife Solutions made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2090 holding.
  • BNP Paribas Asset Management first reported a position in BioLife Solutions in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's BioLife Solutions position peaked at $19.2K in Q1 2026.
  • 159 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.